Thomas F. Deuel

Thomas F. Deuel

President bij Edward R. Mallinckrodt Foundation

89 jaar
Consumer Services
Health Technology
Commercial Services

Profiel

Dr. Thomas F.
Deuel
, MD, is Independent Director at Enzon Pharmaceuticals, Inc., a Director-Vascular Biology Affinity Group at The Scripps Research Institute, a Professor-Emeritus at Harvard Medical School, President at Edward R.
Mallinckrodt Foundation, and a Member at Institute of Medicine.
He is on the Board of Directors at Enzon Pharmaceuticals, Inc. Dr. Deuel also served on the board at ImClone Systems, Inc. and Beth Israel Hospital.
Dr. Deuel received his undergraduate degree from Princeton University and a doctorate degree from Columbia University.

Actieve functies van Thomas F. Deuel

BedrijvenFunctieBegin
Corporate Officer/Principal 01-02-2002
Edward R. Mallinckrodt Foundation President -
Harvard Medical School Corporate Officer/Principal 01-01-1998
Corporate Officer/Principal -
Corporate Officer/Principal -
Alle actieve functies van Thomas F. Deuel

Eerdere bekende functies van Thomas F. Deuel

BedrijvenFunctieEinde
ENZON PHARMACEUTICALS, INC. Director/Board Member 22-10-2013
Director/Board Member 24-11-2008
Corporate Officer/Principal 01-01-2002
Ervaring van Thomas F. Deuel in detail bekijken

Opleiding van Thomas F. Deuel

The Trustees of Columbia University in The City of New York Doctorate Degree
Princeton University Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Thomas F. Deuel in detail bekijken

Connecties

100 +

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
ENZON PHARMACEUTICALS, INC.

Health Technology

Bedrijven in privébezit5

Health Technology

Health Services

Commercial Services

Commercial Services

Edward R. Mallinckrodt Foundation

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Thomas F. Deuel